The effects of the COVID-19 pandemic on patients with obesity undergoing bariatric care

Surg Obes Relat Dis. 2021 Oct;17(10):1714-1720. doi: 10.1016/j.soard.2021.05.026. Epub 2021 May 27.

Abstract

Background: Patients with obesity are at increased risk of developing severe COVID-19. The pandemic has caused delays in preoperative preparation, progression, and completion of bariatric surgeries.

Objectives: The aim of this study was to evaluate the impact of COVID-19 restrictions on bariatric surgery patients and assess their concern of COVID-19 as they continue the preoperative process.

Setting: Philadelphia, Pennsylvania METHODS: A questionnaire was administered to patients to assess the impact of COVID-19 on their weight loss goals, physical activity, and diet. Time points assessed were initial bariatric consultation (T1), as well as the beginning (T2), and the end (T3) of lockdown restrictions in the region.

Results: Seventy-four participants were invited and 50 completed the survey, for a response rate of 67.6%. The average age of participants was 44.1 years. Two-thirds of patients reported significant concern that COVID-19 would affect their weight loss goals. Patients reported significant improvements in their diet from T1 to T2 (P < .01). However, at T3, some patients returned to behaviors held at T1, with snacking behaviors significantly increasing between T2 and T3 (P < .01). Physical activity decreased in 60% of patients between T2 to T3. The vast majority (90%) wanted to have their surgery as soon as possible; 56% reported low levels of concern for COVID-19 infection.

Conclusion: Bariatric patients were highly motivated to proceed with bariatric surgery despite the risks imposed by the pandemic.

Keywords: Bariatric surgery; COVID-19; Elective surgery; Obesity; SARS-CoV-2.

MeSH terms

  • Adult
  • Bariatric Surgery*
  • COVID-19*
  • Communicable Disease Control
  • Humans
  • Obesity / epidemiology
  • Obesity / surgery
  • Obesity, Morbid* / epidemiology
  • Obesity, Morbid* / surgery
  • Pandemics
  • SARS-CoV-2